Amandeep Khatter

Amandeep Khatter

Auto-generated profile, based on publicly available information

Amandeep Khatter

School of Population Health and Environmental Sciences King's College London London UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Learned Publishing
Verified
Journal Article
Open access
PDF file
AKAmandeep Khatter
Amandeep Khatter
MNMichael Naughton
Michael Naughton
HDHajira Dambha-Miller
Hajira Dambha-Miller
PRPatrick Redmond
Patrick Redmond
The impact of COVID‐19 has underlined the need for reliable information to guide clinical practice and policy. This urgency has to be balanced against disruption to journal handling capacity and the continued need to ensure scientific rigour. We examined the reporting quality of highly disseminated COVID‐19 research papers using a bibliometric analysis examining reporting quality and risk of bias (RoB) amongst 250 top scoring Altmetric Attention Score (AAS) COVID‐19 research papers between January and April 2020. Method‐specific RoB tools were used to assess quality. After exclusions, 84 studies from 44 journals were included. Forty‐three (51%) were case series/studies, and only one was an randomized controlled trial. Most authors were from institutions based in China (n = 44, 52%). The median AAS and impact factor was 2015 (interquartile range [IQR] 1,105–4,051.5) and 12.8 (IQR 5–44.2) respectively. Nine studies (11%) utilized a formal reporting framework, 62 (74%) included a funding statement, and 41 (49%) were at high RoB. This review of the most widely disseminated COVID‐19 studies highlights a preponderance of low‐quality case series with few research papers adhering to good standards of reporting. It emphasizes the need for cautious interpretation of research and the increasingly vital responsibility that journals have in ensuring high‐quality publications.

11 October 2026 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
RJRyan Jayesinghe
Ryan Jayesinghe
AKAmandeep Khatter
Amandeep Khatter
SDStevo Durbaba
Stevo Durbaba
MAMark Ashworth
Mark Ashworth
BJBenjamin Jacob
Benjamin Jacob
PRPatrick Redmond
Patrick Redmond
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods: Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across 41 GP practices in South London (2014–2019). The study included patients aged 45–64 years prescribed ≥1 medicines in each year from 2014 to 2019 ( n = 46 633–52 582). PIP was identified using the 22 PROMPT (PRescribing Optimally in Middle‐aged People's Treatments) criteria. Multilevel negative binomial regression estimated associations with patient‐ and practice‐level characteristics, expressed as rate ratios (RR) with 95% confidence intervals. Results: PIP prevalence was 18%–20%, stable across the study period. Practice‐level prevalence ranged from 14% to 24%. The SCV was 1.72 (low) and the ICC was 0.08, with approximately 8% of variance attributable to practice‐level differences. Polypharmacy was the strongest predictor (adjusted RR 4.04, 95% CI 3.96–4.11), followed by multimorbidity (RR 2.44, 95% CI 2.40–2.50). Black/African/Caribbean/Black British ethnicity was associated with lower PIP (RR 0.77, 95% CI 0.75–0.78). Practice‐based pharmacist presence and teaching practice status were associated with modestly lower PIP, while APMS contract type was associated with higher PIP (RR 1.20, 95% CI 1.10–1.32). Conclusion: Most variation occurred at the patient level, but practice organizational characteristics were also associated with PIP and warrant further investigation in an age group for which direct medicines‐optimization evidence remains limited.